901459837

901459837



A (^ TD American College of Physicians

L 1V> JL INTERNAL MBDICINE I DotlOTł /or Adulti

LABORATORY VALU ES

US tiaditiołulurnts ite foliowedmpai*nduses by eqxuvalent valu*5 expiessedmSI tuuts

Hematology

Abicku want jiii ccnut

hUe me-sm/nLa7S4*i *ic /l>

Femile — 1SK-413C />L a Se-t 15 >: 1C' 7L)

A<tvatfi painal *bzc zaBcp la stoi t®u —i5-J5 s Bke im* tzsnr —less tkań 10 min Ezytkzccyrc cent —4 2-5.9 k 10 /pL (4 2-5 9 x 10 /L) Ezytkzccyte irlaMntatsiiutt Małe —0-15 mm/h Fe małe —0*20 »iu/h

CiytkcptitB —less tkań 50 mU/iuL (50 uiuts/L)

D-Dnari —less tkań 0 5 iig/mL (0.5 mg/1) rcuuzn seium — 15*200 ng/mL (15-200 ng/L) Haptugklń. senun -50-150 mg/dL (500-1500 mg/L) Hfifcril

Małe —41%-51%

Fe małe —36%-47%

Hruc^kln Uood

Małe —14-17 g/ dL (140-170 g /L)

Fe małe —12rl6 g/dL (120-160 g/L)

Leuiccytc Alikif pLcspkataie -15-40 mg tfpktspktius kbeiatr d/kpei 10 cells, sctie = 15-150/100 pdymtipktautle ai neutitpłuls and kud ttims Lemiecyte cc itt —4000-10,000/pL (4 0-10 x 10 /L)

Meazi cc sfiucmki Lfziu 'klm—28-32 pg Me as cesf tu c ulu LemcgkbiŁ cescennatss —52-50 g/dL (320-360 g/L)

Me as ccsyuscuiai v«k&u —80-100 fL

Flatckt (•«« — 150,000-350,000/ pL (150-350 a 10 /L)

Fxc tki< Klin: tacie —11-13 s

Reracmlicyte ccmsT —0 5%-l 5% of flytkjocytrs; absdutr

23,000-90,000/ pL (23-90 x 10 7 L)

Blood, PI a i ma, and Serum Chemistry Studies

AIną xna —ł.J-1 5 g/dL (J5-55 g/L)

Al albie pbnjkauie, serum —56-92 umts/L C-retefsetem, senun —0-20 ng/mL (0-20 ng/L)

Ance naEskusc, ahnire (ALT) —0-35 uiuts/L Anwienassśriaie, as pasta Te (AST) —0-35 ujuts/L Aaasaessi. plasma -40-80 Mg/dL (23-47 *md/L)

Asayłase serum—0-130 umts/L

BkaaUsate. senun -25-28 me)/L (25-28 mmol/L)

BikitiŁ serum

Te tal—0 3-12 mg/dL (5.1-20 5 itm«l/L)

Dseet—0-0 3 mg/dL (0-5.1 »imd/L)

Bk c i jmm, artrnal (amtuentau) jH -7 38-7 44

Fce: —35-45 mm Hg (47-6.0 iFa)

Fe2 —80* 100 mm Hg (10 6-13.3 iPa)

Orygen ittsinsa —95*/» o i gieatei Bk c i mzea nkzcgen—8-20 mg/dL (29-7 1 mmol/L) C-xeactaue j:c tes —0.0-0 S mg/dL 0-8 0 mg/L)

Caksu* senun — 9-10 5 mg/dL (22-26 mmol/L)

CuUr ia)alc, serum —See Etcaibenate Ckfczile. senun —98-106 me t[/L (98-106 mmtl/L)

CŁc lesteze i plasma

Tetal—150-199 mg/dL(3 8S-5 15 mm d/L), desuable U% -dfBsfylfcfxet<B (LDL)—less tkam «i e^ual te 150 smg/dL (3 56 mm d/L), desuable

H^k-drmty bycjioten (HDL)—gieatei tkam ue^ul t# 40 mg/dL (104 mmol/L), desuable Cc saplrssest, senun

C5 -55-120 mg/dL (550-1200 mg/L)

Te tal (CH.) -37-55 U/mL (37-55 1U/L)

Cseatme imase, seium —50-170 mmts/L CzeataEŚse, serum —0 7-13 mg/dL (619-115 urn d/L) Elrcncktes, senun

Scdżarn —156-145 me j/L (136-145 mm d/L)

Fatassmna — 3 5-5 0 me ^/L (3.5-5 0 mm d/L)

CLfeirfc -98-106 me )/L (98-106 mm d/L)

EkazBosate -23-28 me^/L (23-2S mm d/L) rakzBsges, plasma —150-350 mg/dL (15-3 5 g/L)

Fela te. le d celi —160*855 ng/m L (362-1937 nmd/L)

Fe la te senun —25-20 ng/mL (5.7-45 3 lund/L)

Ckucse. plasma —fastuig, 70-100 mg/dL (3 9-5 6 mm d/L) f-Gljnaiityrluaiisfcłase, serum —0-50 umts/L He za*cysteinę, plasma

Małe —0.54-216 mg/L (4-16 |uud/l)

Fe małe — 0.41-1 89 mg/L (3-14 jamd/L)

I—mgkbtiB

Ok iukns tital -25-3.5 g/dL (25-35 g/L)

IgG -640-1430 mg/dL (6 4-14.3 g/L)

Ig A-70-300 mg/dL 0 7-3.0 g/L)

IgM—20-140 mg/dL ^>.2-1.4 g/L)

IgD —less tluui 8 mg/dL <80 mg/L)

IgE —0 01-0.04 mg/dL (0 1-0 4 mg/L)

Iztn sraiies

rtiiBB, senun —15-200 ng/mL (15-200 ng/L)

Len, serum —60-160 ng/dL (11-29 pund/L)

Łcii lndiii* capacky, te tal, seium —250-460 pg/iL (45-82 nmd/L)

Tiansirzzki satmatkn —20%-50*A Lactatr de bydiegcnase, senun -60-100 umts/L Lactk acal. venous bit od —6-16 mg/dL (0 67-18 mmtl/L) Lipasc, seium —less tkaa 95 suuts/L Magueinu senun —15-24 mg/dL (0 62-0 99 mm d/L) Metlzyimalpnk acil, seium —150-370 nmd/L Osnaclalry, plasma —275-295 mtsm/ig H O Fłicspkatase aŁakmc, senun —36-92 umts/L FLc s pbc xns. se nun — 3-4 5 mg / dL (0 97-145 mm d/L)

Fet as mm senun —3 5-5 0 mc «j/L (3 5-5 0mmd/L)

Fzc sta te-spe cifie antigen, senun —less tkań 4 ng/mL

Fletem, sfnun

Tctal—6 0-78 g/dL (60-78 g/L)

Alma. — J J-5 5 g/dL (M-6J g/L)

Ck lnlms tetai—25-3 5 g/dL (2i-35 g/L)

RLtsmated fccKI —Ust tłuin 40 U/mL (40 kU/L) Sednem. s«nun —156-14i mt^/L (li6-14> mmU/L) Tiuufcnn unujteii — 20%- 50*/«

T:i»V<łi«łn —Ust t)uui 150 mg/dL (169 mi!/L),

Mdk

Ttefenms, senun

T!«|eea X —0 0 5 ng/mL (0-0 5 |>g/L)

T:c i«ŁiŁ T—0-0.10 ng/mL (0-0 10 pg/1)

Usea nanegen. U«*d—8-20 mg/dL^9-7 1 nmd/L)

Ulic acd, ttnun —25-8 mg/dL (P 15-0.47 mmtl/L)

B,., senun — 200-SOO pg/mL (143-590 pmtl/L)



Wyszukiwarka

Podobne podstrony:
Choroby układowe tkanki łącznej (3) RZS - okresy wg obrazu RTG (Steinbrocker) RZS - kryteria ACR (A
img001 (49) CM3RURGJA OWKOŁOG3CEMARozpoznanie i leczenie raka płucaZaktualizowane (2007) wytyczne Am
IMGP2445 ACR Criteria for the Classlfication of Polyarteritis Nodosa (RAN) American College of Rheum
IMGP2445 ACR Criteria for the Classlfication of Polyarteritis Nodosa (RAN) American College of Rheum
14080 img001 (49) CM3RURGJA OWKOŁOG3CEMARozpoznanie i leczenie raka płucaZaktualizowane (2007) wytyc
American College of Allergy, Asthma and Immunology (ACAAI) Guidance on Risk of Allergic Reactions to
American College of Allergy, Asthma and Immunology (ACAAI) Guidanceon Riskof Allergic Reactions to
American College of Allergy, Asthma and Immunology(ACAAI) Guidanceon Risk of Allergic Reactionsto mR
American College of Allergy, Asthma and Immunology(ACAAI) Guidanceon Risk of Allergic Reactionsto mR
American College of Allergy, Asthma and Immunology(ACAAI) Guidanceon Risk of Allergic Reactionsto mR
img001 (49) CM3RURGJA OWKOŁOG3CEMARozpoznanie i leczenie raka płucaZaktualizowane (2007) wytyczne Am
DSC02030 Kryteria rozpoznania RZS wg. ACR (American College of Rheumatology) 1987 i. 1.   
Kryteria klasyfikacyjne American College of Rheumatology 1.    Obecość kryształów
PA200118 [1600x1200] Podział wód pod względem czyst (The American Society for Testini (College
PA200120 [1600x1200] Podział wód pod względem czyst (The American Society for Testini (College
ENGINEERING PHYSICS-II LABORATORY MANUAŁI. B.TECH, II SEMESTER - ALL BRANCHES GAYTRI VIDYA PARISHAD
vpcoe VU>YA PRATISHTHAN S COLLEGE OF ENGINEERING, BARAMAT1 FIRSTSOBJECT: PHYSICSSubj ect Codę: (1

więcej podobnych podstron